Martin Tenlen

Martin Tenlen is a commercial leader at CSL, currently pursuing a BA in Finance at the University of Utah's David Eccles School of Business. Previously, Martin held significant roles at CSL, including General Manager for Austria and the Nordic Region, and Global Marketing Director, managing a rare disease franchise with over $2 billion in annual revenue. Martin's career includes experience at AstraZeneca, where they progressed through various sales and marketing positions, culminating in the launch of a $1 billion primary care opportunity. With a background that started in investment advising at Fidelity Investments, Martin has demonstrated a diverse skill set and commitment to driving growth in the pharmaceutical industry.